Literature DB >> 26475595

Aortic Aging in ESRD: Structural, Hemodynamic, and Mortality Implications.

Gérard M London1, Michel E Safar2, Bruno Pannier3.   

Abstract

Aging incurs aortic stiffening and dilation, but these changes are less pronounced in peripheral arteries, resulting in stiffness and geometry gradients influencing progression of the forward and reflected pressure waves. Because premature arterial aging is observed in ESRD, we determined the respective roles of stiffness and aortic geometry gradients in 73 controls and 156 patients on hemodialysis. We measured aortic pulse wave velocity (PWV) and brachial PWV to evaluate the stiffness gradient [(brachial PWV/aortic PWV)(0.5)] and ascending aortic and aortic bifurcation diameters to assess aortic taper (ascending aortic diameter/aortic bifurcation diameter). The global reflection coefficient was estimated from characteristic impedance and vascular resistance. Cox proportional hazard models were used to determine mortality risk. The age-associated increase in aortic PWV was higher in patients (P<0.001). In controls, aortic ascending and bifurcation diameters increased with age, with an unchanged aortic taper. In patients on hemodialysis, age did not associate with increased ascending aortic diameter but did associate with increased aortic bifurcation diameter and decreased aortic taper, both of which also associated with abdominal aortic calcifications and smaller global reflection coefficient (P<0.001). In patients, multivariate models revealed all-cause and cardiovascular mortality associated with age, aortic PWV, and aortic bifurcation diameter with high specificity and sensitivity. Using stiffness gradient, aortic taper, or global reflection coefficient in the model produced similar results. Thus, whereas aortic stiffness is a known independent predictor of mortality, these results indicate the importance of also evaluating the aortic geometry in patients on hemodialysis.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  arteries; cardiovascular disease; chronic kidney failure; mortality; pulse wave velocity; vascular calcification

Mesh:

Year:  2015        PMID: 26475595      PMCID: PMC4884119          DOI: 10.1681/ASN.2015060617

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  48 in total

1.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

2.  Two arterial effective reflecting sites may appear as one to the heart.

Authors:  R Burattini; G G Knowlen; K B Campbell
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

3.  Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients.

Authors:  Léon H G Henskens; Abraham A Kroon; Robert J van Oostenbrugge; Ed H B M Gronenschild; Monique M J J Fuss-Lejeune; Paul A M Hofman; Jan Lodder; Peter W de Leeuw
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

4.  Morphological and functional characteristics of isolated resistance vessels in advanced uraemia.

Authors:  C Aalkjaer; E B Pedersen; H Danielsen; O Fjeldborg; B Jespersen; T Kjaer; S S Sørensen; M J Mulvany
Journal:  Clin Sci (Lond)       Date:  1986-12       Impact factor: 6.124

5.  Cardiac and arterial interactions in end-stage renal disease.

Authors:  G M London; A P Guerin; S J Marchais; B Pannier; M E Safar; M Day; F Metivier
Journal:  Kidney Int       Date:  1996-08       Impact factor: 10.612

6.  Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities.

Authors:  R Virmani; A P Avolio; W J Mergner; M Robinowitz; E E Herderick; J F Cornhill; S Y Guo; T H Liu; D Y Ou; M O'Rourke
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

7.  Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.

Authors:  G M London; B Pannier; A P Guerin; S J Marchais; M E Safar; J L Cuche
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

Review 8.  Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage.

Authors:  Gary F Mitchell
Journal:  J Appl Physiol (1985)       Date:  2008-09-04

Review 9.  Mechanical factors in arterial aging: a clinical perspective.

Authors:  Michael F O'Rourke; Junichiro Hashimoto
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

10.  Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility.

Authors:  Alastair J S Webb; Michela Simoni; Sara Mazzucco; Wilhelm Kuker; Ursula Schulz; Peter M Rothwell
Journal:  Stroke       Date:  2012-08-23       Impact factor: 7.914

View more
  23 in total

1.  Targeting Blood Vessel Stiffness to Protect Kidney Function.

Authors:  Neeraj Dhaun; David J Webb
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 8.237

Review 2.  Systolic and diastolic hypertension among patients on hemodialysis: Musings on volume overload, arterial stiffness, and erythropoietin.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Semin Dial       Date:  2019-08-28       Impact factor: 3.455

3.  Trends in Rates of Lower Extremity Amputation Among Patients With End-stage Renal Disease Who Receive Dialysis.

Authors:  Douglas Franz; Yuanchao Zheng; Nicholas J Leeper; Venita Chandra; Maria Montez-Rath; Tara I Chang
Journal:  JAMA Intern Med       Date:  2018-08-01       Impact factor: 21.873

Review 4.  Arterial Stiffness and the Canonical WNT/β-catenin Pathway.

Authors:  Alexandre Vallée
Journal:  Curr Hypertens Rep       Date:  2022-06-21       Impact factor: 4.592

Review 5.  Blood Pressure and Mortality in Long-Term Hemodialysis-Time to Move Forward.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Am J Hypertens       Date:  2017-03-01       Impact factor: 2.689

Review 6.  Diagnosis and Management of Pulmonary Hypertension in Patients With CKD.

Authors:  Carl P Walther; Vijay Nambi; Nicola A Hanania; Sankar D Navaneethan
Journal:  Am J Kidney Dis       Date:  2020-03-19       Impact factor: 8.860

7.  Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis.

Authors:  Panagiotis I Georgianos; Fani Mpoutsiouki; Erasmia Sabani; Dimitrios N Stamatiadis; Vassilios Liakopoulos; Elias V Balaskas; Pantelis E Zebekakis; Pantelis A Sarafidis
Journal:  Int Urol Nephrol       Date:  2016-01-14       Impact factor: 2.370

8.  Association between serum indoxyl sulfate levels with carotid-femoral pulse wave velocity in patients with chronic kidney disease.

Authors:  Sheng-Chao Wang; Yu-Hsien Lai; Chin-Hung Liu; Chih-Hsien Wang; Bang-Gee Hsu; Jen-Pi Tsai
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

9.  Sex and the G Protein-Coupled Estrogen Receptor Impact Vascular Stiffness.

Authors:  Benard O Ogola; Gabrielle L Clark; Caleb M Abshire; Nicholas R Harris; Kaylee L Gentry; Shreya S Gunda; Isabella Kilanowski-Doroh; Tristen J Wong; Bruna Visniauskas; Dylan J Lawrence; Margaret A Zimmerman; Carolyn L Bayer; Leanne Groban; Kristin S Miller; Sarah H Lindsey
Journal:  Hypertension       Date:  2021-05-24       Impact factor: 9.897

10.  "Epigenome-wide methylation profile of chronic kidney disease-derived arterial DNA uncovers novel pathways in disease-associated cardiovascular pathology."

Authors:  Athina Dritsoula; Maria Kislikova; Amin Oomatia; Amy P Webster; Stephan Beck; Markella Ponticos; Ben Lindsey; Jill Norman; David C Wheeler; Thomas Oates; Ben Caplin
Journal:  Epigenetics       Date:  2020-09-15       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.